A nurse is caring for a client in an acute care setting.

Exhibits

The client is at risk for ________ as evidences by __________.

Complete the following sentence by using the list of options. Pick 2 choices.

Choice A rationale:

A 12-lead ECG (electrocardiogram) is the priority diagnostic test for a patient with symptoms suggestive of chest pain and a potential cardiac event. Chest pain and a feeling of heaviness on the chest can be indicative of various cardiac conditions, including myocardial infarction (heart attack). A 12-lead ECG provides valuable information about the heart's electrical activity, helping healthcare providers assess for signs of ischemia, arrhythmias, or myocardial infarction. Early detection and intervention are crucial in cardiac emergencies, making

The correct answer is choice C: Initiate continuous cardiac monitoring.

Choice A rationale:

Implementing fluid restrictions is not recommended for a child with diabetic ketoacidosis (DKA). DKA is characterized by severe dehydration due to osmotic diuresis, and fluid replacement is a critical component of treatment to restore hydration and circulatory volume.

Choice B rationale:

Monitoring vital signs every 8 hours is not sufficient for a child with DKA. DKA is an acute, life-threatening condition that requires close monitoring of vital signs to detect changes in the patient’s condition promptly. Vital signs should be monitored more frequently, typically every 1 to 2 hours, depending on the severity of the DKA and institutional protocols.

Choice C rationale:

Continuous cardiac monitoring is recommended for a child with DKA. DKA can lead to serious electrolyte imbalances, such as hypokalemia, which can cause cardiac arrhythmias. Continuous cardiac monitoring allows for the early detection and treatment of these potential complications.

Choice D rationale:

Administering subcutaneous insulin 30 minutes before meals is not appropriate for the acute management of DKA. In DKA, insulin is typically administered intravenously to rapidly decrease blood glucose levels and correct metabolic acidosis. Subcutaneous insulin is not used until the patient is stable and able to eat.